Benlysta (Belimumab) Market Forecast: Opportunitie..

skapat en ny artikel

23 i - Översätt

Benlysta (Belimumab) Market Forecast: Opportunities and Challenges to 2030 | #benlysta (belimumab) # Benlysta (belimumab) Marketed Drugs Overview # Benlysta (belimumab) Market Assessment

Benlysta (Belimumab) Market Forecast: Opportunities and Challenges to 2030

Benlysta (belimumab), developed by GlaxoSmithKline (GSK), is a monoclonal antibody designed to target and inhibit B-lymphocyte stimulator (BLyS), a protein essential for the survival of B cells.

Tycka om

Kommentar

Dela med sig

23 i - Översätt

Benlysta (Belimumab) Market Forecast: Opportunities and Challenges to 2030

Språk